Results 41 to 50 of about 87,371,428 (168)

Understanding Factors Contributing to the Birthing Experiences of People With Substance Use Disorder: A Qualitative Study With Healthcare Clinicians

Birth, EarlyView.
ABSTRACT Introduction Despite evidence supporting comprehensive treatment for perinatal substance use disorder (SUD), access and engagement in these programs remain limited due to structural barriers, stigma, and bias. Pregnant people with SUD thus often enter birth hospitalization after negative—or absent—healthcare experiences.
Margaret J. Sherin, India R. Burdon Dasbach, Cheri L. Bryer, Katherine Olivia P. Stokes, Daisy J. Goodman   +4 more
wiley   +1 more source

The Effect of Opioid Abatement Funds on the Utilization of Medications for Opioid Use Disorder

Health Services Research, Volume 61, Issue 6, December 2026.
ABSTRACT Objective To evaluate whether opioid abatement fund allocations to treatment programs influence the utilization of medications for opioid use disorder (MOUD). Study Setting and Design The study employed a synthetic difference‐in‐differences design and a triple‐differences model using a state‐year panel to estimate the effects of abatement fund
Jiajing Scarlette Shi, Hefei Wen
wiley   +1 more source

Factors associated with retention on medications for opioid use disorder among a cohort of adults seeking treatment in the community

Addiction Science & Clinical Practice, 2022
Background Medication treatment for opioid use disorder (OUD) (MOUD; buprenorphine and methadone) reduces opioid use and overdose. Discontinuation of MOUD can quickly lead to relapse, overdose and death.
Breanne E. Biondi, Brent Vander Wyk, Esther F. Schlossberg, Albert Shaw, Sandra A. Springer   +4 more
doaj   +1 more source

Impact of opioid use disorder on oxytocin required for labor induction in term pregnancies

Pregnancy, Volume 2, Issue 6, November 2026.
Abstract Objective Oxytocin is a neuropeptide proven to impact human labor, lactation, and social affinity and is of interest in the study of pain and μ‐opioid receptor modulation. Individuals impacted by opioid use disorder (OUD) frequently have μ‐opioid receptor dysregulation.
Hansika Kunduru, Judy Jiang, Hannah Hill, Jessica Wilder   +3 more
wiley   +1 more source

Use of a Decision Aid in Medication Initiation Among Patients with Opioid Use Disorder and HIV [PDF]

, 2023
Opioid use disorder refers to the maladaptive use of prescribed or illicit opioids. This condition can be treated using pharmacotherapy referred to as medications for opioid use disorder (MOUD), but they are underutilized.
Gateley, Katrina
core  

Retention Challenges in Opioid Use Disorder Treatment: The Role of Comorbid Psychological Conditions

Western Journal of Emergency Medicine
Introduction: Comorbid psychological conditions have an impact on opioid use disorder (OUD). We measured multiple psychological tests in OUD patients who entered an emergency department (ED)-based medication for opioid use disorder (MOUD) program to ...
David C. Seaberg, Jamie McKinnon, Lyn Haselton, Patrick Palmieri, Jason Kolb, Suman Vellanki, Mary Moran, J. Chika Morah, Nicholas Jouriles   +8 more
doaj   +1 more source

Baseline Characteristics and Postdischarge Outcomes by Medication for Opioid Use Disorder Status Among Women with Polysubstance Use in Residential Treatment

Women's Health Reports, 2023
Background: Within residential treatment, medication for opioid use disorder (MOUD) is rarely offered, so little is known about group differences by MOUD status.
Anna Beth Parlier-Ahmad, Sydney Kelpin, Caitlin E. Martin, Dace S. Svikis   +3 more
doaj   +1 more source

Real‐world comparative effects of slow‐release oral morphine vs. methadone on healthcare use for opioid use disorder: A population‐based target trial emulation

Addiction, Volume 121, Issue 11, Page 3040-3052, November 2026.
Abstract Aims To examine the comparative effects of slow‐release oral morphine (SROM) vs. methadone for the treatment of opioid use disorder (OUD) on healthcare use. Design This retrospective cohort study emulated a target trial using electronic medical record data from Vancouver Coastal Health Authority linked with population‐based administrative ...
Vivienne Y. Zhou, Nadia Fairbairn, Jingxin Lei, Rupinder Brar, Paxton Bach, M. Eugenia Socias   +5 more
wiley   +1 more source

The impact of COVID-19 on the treatment of opioid use disorder in carceral facilities: a cross-sectional study

Health & Justice, 2022
While the COVID-19 pandemic disrupted healthcare delivery everywhere, persons with carceral system involvement and opioid use disorder (OUD) were disproportionately impacted and vulnerable to severe COVID-associated illness.
Elizabeth C. Saunders, Milan F. Satcher, Laura B. Monico, Ryan D. McDonald, Sandra A. Springer, David Farabee, Jan Gryczynski, Amesika Nyaku, Donald Reeves, Lynn E. Kunkel, Alysse M. Schultheis, Robert P. Schwartz, Joshua D. Lee, Lisa A. Marsch, Elizabeth Needham Waddell   +14 more
doaj   +1 more source

A conceptual framework for how structural changes in emerging acute substance use service models can reduce stigma of medications for opioid use disorder

Frontiers in Psychiatry, 2023
Stigma toward people taking medication for opioid use disorder (MOUD) is prevalent, harmful to the health and well-being of this population, and impedes MOUD treatment resource provision, help-seeking, and engagement in care.
Timothy D. Becker, Timothy D. Becker, Evan L. Eschliman, Ashish P. Thakrar, Lawrence H. Yang, Lawrence H. Yang   +5 more
doaj   +1 more source